UnitedHealth/$UNH
1D1W1MYTD1Y5YMAX
Capital at risk
About UnitedHealth
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
- Ticker
- $UNH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 390,000
- Headquarters
- Eden Prairie, United States
- Website
- www.unitedhealthgroup.com
UnitedHealth Metrics
BasicAdvanced
$360B
25.80
$15.53
0.63
$8.95
2.32%
Price and volume
Market cap
$360B
Beta
0.63
52-week high
$461.62
52-week low
$255.97
Average daily volume
4.3M
Dividend rate
$8.95
Financial strength
Current ratio
0.777
Quick ratio
0.474
Long term debt to equity
65.599
Total debt to equity
69.211
Dividend payout ratio (TTM)
57.33%
Interest coverage (TTM)
6.19%
Profitability
EBITDA (TTM)
26,681
Gross margin (TTM)
19.72%
Net profit margin (TTM)
3.13%
Operating margin (TTM)
5.35%
Effective tax rate (TTM)
14.50%
Revenue per employee (TTM)
$1,160,000
Management effectiveness
Return on assets (TTM)
4.87%
Return on equity (TTM)
14.15%
Valuation
Price to earnings (TTM)
25.805
Price to revenue (TTM)
0.806
Price to book
3.68
Price to tangible book (TTM)
3.47
Price to free cash flow (TTM)
15.369
Free cash flow yield (TTM)
6.51%
Free cash flow per share (TTM)
26.082
Dividend yield (TTM)
2.23%
Forward dividend yield
2.32%
Growth
Revenue change (TTM)
6.55%
Earnings per share change (TTM)
-32.80%
3-year revenue growth (CAGR)
8.93%
10-year revenue growth (CAGR)
9.85%
3-year earnings per share growth (CAGR)
-11.40%
10-year earnings per share growth (CAGR)
9.29%
3-year dividend per share growth (CAGR)
9.43%
10-year dividend per share growth (CAGR)
15.46%
What the Analysts think about UnitedHealth
Analyst ratings (Buy, Hold, Sell) for UnitedHealth stock.
Analyst projections of the future price of UnitedHealth stock.
Bulls say / Bears say
UnitedHealth beat Wall Street’s second-quarter profit expectations, posting adjusted EPS of $6.38 versus a $4.90 consensus and raised its full-year 2026 adjusted EPS guidance to $19.50–$20.00 per share. (Reuters)
Optum’s second-quarter operating income jumped 29% year-over-year to $4 billion, driven by improved operations in its technology and clinical units. (Reuters)
In its 8-K filing, UnitedHealth raised its share repurchase authorization to at least $5 billion for 2026 (up from ~$2.5 billion) and projects ~$24 billion in cash flows from operations, underscoring strong free cash flow and capital discipline. (8-K Filing)
UnitedHealthcare membership fell by approximately 525,000 in the second quarter, signaling potential pressure on premium revenue growth. (Reuters via Hindustan Times)
Massachusetts sued a UnitedHealth insurance unit, accusing it of defrauding the state’s Medicaid program of at least $100 million, highlighting regulatory and reputational risk. (Reuters)
The Department of Justice’s criminal division is expanding its probe into Optum Rx’s prescription management practices, posing potential legal and financial exposure. (Bloomberg News)
Data summarised monthly by Lightyear AI. Last updated on 26 Aug 2026.
UnitedHealth Financial Performance
Revenues and expenses
UnitedHealth Earnings Performance
Company profitability
Upcoming events
UnitedHealth News
AllArticlesVideos
Funds containing UnitedHealth
AllEURGBPUSD
Fund name | Fund size | $UNH weighting |
|---|---|---|
iShares S&P 500 Health Care Sector€IUHE | €125M | 6.44% |
iShares Dow Jones Industrial Average€EXI3 | €315M | 4.50% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 4.22% |
Vanguard FTSE All-World High Dividend Yield€VHYL | €9.9B | 0.86% |
Vanguard FTSE All-World High Dividend Yield£VHYL | £8.5B | 0.86% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.